
| Pair Name | Polydatin, Brusatol | ||
| Phytochemical Name | Polydatin (PubChem CID: 5281718 ) | ||
| Anticancer drug Name | Brusatol (PubChem CID: 73432 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Polydatin, Brusatol | |||
| Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
| Gene Regulation | Down-regulation | Expression | NFE2L2 | hsa4780 |
| Down-regulation | Expression | HMOX1 | hsa3162 | |
| Down-regulation | Expression | NQO1 | hsa1728 | |
| In Vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 |
| SUM159PT | Breast pleomorphic carcinoma | Homo sapiens (Human) | CVCL_5423 | |
| In Vivo Model | MDA-MB-231 (100 μL containing 5×10⁶ cells) were injected subcutaneously into nude mice. Until the tumor volume reached 100–200 mm3, mice in the individual administration groups were injected intraperitoneally with PD 50 mg/kg, the combined administration group was PD 25 mg/kg and BRU 1 mg/kg. | |||
| Result | We could significantly reduce tumor cell growth while avoiding toxic side effects, providing a treatment method with greater clinical application value for TNBC treatment. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway. Int J Mol Sci. 2023 May 5;24(9):8265. doi: 10.3390/ijms24098265. | Click |